Basic Information
Basic information for LINC00343-323-13aa-2
Peptide Name LINC00343-323-13aa-2
Genome Position chr13:105764209-105764247[+]
Species Human
Peptide Sequence MVFHLKRLNKGSD
Peptide Length 13
Unique No (LINC00343-202-13aa-1,LINC00343-225-13aa-2,LINC00343-232-13aa-1,LINC00343-243-13aa-1,LINC00343-250-13aa-2,LINC00343-252-13aa-2,LINC00343-253-13aa-2,LINC00343-255-13aa-1,LINC00343-257-13aa-2,LINC00343-258-13aa-3,LINC00343-262-13aa-2,LINC00343-264-13aa-2,LINC00343-270-13aa-2,LINC00343-291-13aa-2,LINC00343-293-13aa-2,LINC00343-294-13aa-1,LINC00343-303-13aa-1,LINC00343-315-13aa-2,LINC00343-321-13aa-2,LINC00343-324-13aa-2,LINC00343-326-13aa-2,LINC00343-328-13aa-1)
Grand Average of Hydropathicity -0.5538
Relative Molecular Mass 1761.01
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000670771;LINC00343-323
Transcript Length 1983
Coding Ability 0.4937
DNA Sequence Corresponding to Peptide ATGGTTTTTCATTTAAAGAGACTAAATAAAGGTTCTGAC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :